News
The Innovative Health Initiative (IHI) announces new call topics
The Innovative Health Initiative (IHI), a public-private partnership between the European Union and the European life science industries, published information on future calls ahead of publication. The goal is to give applicants additional time to find or build a consortium and prepare a strong proposal.
Wim-Jan Koot, Director of Business Development at Lygature, explains: “Although IHI is a follow up of the Innovative Medicines Initiative (IMI), there are important differences to be aware of when you participate in an IHI call. Most organisations that have worked with IMI in the past have experience with two-stage calls. In these calls, public consortia (excluding EFPIA) first had to submit their proposal for review by IMI. The public consortium with the highest ranked proposal would then have to team up with pre-identified EFPIA partners (private parties) to form the final consortium. In the second stage, this consortium would then have the opportunity to submit the full proposal.”
“As you will see, the majority of current IHI call topics are single stage calls, where both public and private parties have to form a consortium right from the start and jointly submit a proposal. For single stage calls, time and timing is even more important. At Lygature we see many organisations struggle with the idea of collaborating in single stage calls, where also the proposal writing and submission have to be completed in a joint effort.”
Lygature has a lot of experience in both type of calls and with complex multi stakeholder partnerships. Lygature acts as an independent partner to guide complex collaborations and provide much needed infrastructural components to create a consortium.
Are you interested to submit a proposal for one of the IHI calls and want to know how Lygature can support you? Have a look at our IHI page or contact Wim-Jan Koot for more information.